Latest news, press releases, and SEC filings for Quantum Biopharma Ltd (QNTM) https://caymanjournal.com/stock/QNTM en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:32:22 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 📋 What This Document Is 📰 This filing is a Form 6-K, which is a public report used by international companies to announce material, significant events to U.S. investors. 📈 Essentially, it serves as a major corporate announcement regarding the strategic direction, leadership changes, and commerc https://caymanjournal.com/stock/QNTM/sec-filing/0001171843-26-002639 https://caymanjournal.com/stock/QNTM/sec-filing/0001171843-26-002639 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing # 🔥 What This Document Is This is a 6-K filing, which is a **current report** that public companies use to announce major events to shareholders. It contains a **press release** announcing a significant legal victory for Quantum Biopharma. In simple terms, a court has allowed their massive $700 mi https://caymanjournal.com/stock/QNTM/sec-filing/0001171843-26-002207 https://caymanjournal.com/stock/QNTM/sec-filing/0001171843-26-002207 Thu, 02 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **6-K report**, a filing foreign companies use with the SEC to share major news with investors. This specific filing contains a **press release** announcing a major regulatory milestone for their drug candidate. Think of it as an official update to the market on https://caymanjournal.com/stock/QNTM/sec-filing/0001171843-26-002144 https://caymanjournal.com/stock/QNTM/sec-filing/0001171843-26-002144 Wed, 01 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **6-K filing**, which is a report foreign companies (like Canadian-based Quantum) must submit to the SEC to share important news with U.S. investors. Specifically, it's a **press release** announcing a major new partnership to run a clinical trial for their main https://caymanjournal.com/stock/QNTM/sec-filing/0001171843-26-002008 https://caymanjournal.com/stock/QNTM/sec-filing/0001171843-26-002008 Mon, 30 Mar 2026 00:00:00 GMT SEC Filing